• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 17, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Six Purdue innovators advance their technologies through Trask funding

Bioengineer by Bioengineer
June 11, 2020
in Science News
Reading Time: 3 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: Oren Darling/Purdue Research Foundation

WEST LAFAYETTE, Ind. – Six Purdue University researchers have received a total of $212,845 from the Trask Innovation Fund to help their labs commercialize their innovations.

The fund is a development program established to support projects that advance the commercial value of Purdue intellectual property. The fund makes awards twice a year to aid faculty and staff with their patented innovations that are being commercialized through the Purdue Research Foundation Office of Technology Commercialization.

There are three Trask Innovation Fund tracks: Innovation Sparks for Life Science; Innovation Sparks for Physical Sciences; and Commercialization Partner Spark.

The Purdue researchers receiving funding this round:

  • Young Kim, Scalable production and deposition of luminescent silk microparticles for ‘on-dose’ medicine authentication. (track: life science)
  • Pavlos Vlachos, Automated analysis for improved heart health. (track: life science)
  • Philip Low, Development of targeted therapies for idiopathic pulmonary fibrosis. (track: commercialization)
  • Yoon Yeo, Abxtal for cancer immunotherapy. (track: commercialization)
  • James Caruthers, Composite board binder systems from rice lignin. (track: physical sciences)
  • Arman Sabbaghi, Enhancing the commercial value of AMapi: An API for additive manufacturing systems. (track: physical sciences)

“Researchers submitted a lot of technologies worthy of OTC’s investment to create solutions through the Purdue commercialization ecosystem and Purdue’s growing Discovery Park District,” said Abhijit Karve, director of business development for the Purdue Office of Technology Commercialization.

Purdue inventors who are prepared to move their innovations to market have until Sept. 25, 2020, to apply for funding through the Trask Innovation Fund.

###

All Purdue faculty, staff and researchers who have submitted a disclosure to OTC are eligible to submit proposals.

To learn more about these and other Purdue technologies, contact OTC at otcip@prf.org or visit the OTC Inventions page at https://inventions.prf.org/.

About Purdue Research Foundation Office of Technology Commercialization

The Purdue Research Foundation Office of Technology Commercialization operates one of the most comprehensive technology transfer programs among leading research universities in the U.S. Services provided by this office support the economic development initiatives of Purdue University and benefit the university’s academic activities through commercializing, licensing and protecting Purdue intellectual property. The office recently moved into the Convergence Center for Innovation and Collaboration in Discovery Park District, adjacent to the Purdue campus. In fiscal year 2019, the office reported 136 deals finalized with 231 technologies signed, 380 disclosures received and 141 issued U.S. patents. The office is managed by the Purdue Research Foundation, which received the 2019 Innovation and Economic Prosperity Universities Award for Place from the Association of Public and Land-grant Universities. In 2020, IPWatchdog Institute ranked Purdue third nationally in startup creation and in the top 20 for patents. The Purdue Research Foundation is a private, nonprofit foundation created to advance the mission of Purdue University. Contact otcip@prf.org for more information.

About Purdue University

Purdue University is a top public research institution developing practical solutions to today’s toughest challenges. Ranked the No. 6 Most Innovative University in the United States by U.S. News & World Report, Purdue delivers world-changing research and out-of-this-world discovery. Committed to hands-on and online, real-world learning, Purdue offers a transformative education to all. Committed to affordability and accessibility, Purdue has frozen tuition and most fees at 2012-13 levels, enabling more students than ever to graduate debt-free. See how Purdue never stops in the persistent pursuit of the next giant leap at purdue.edu.

Writer: Chris Adam, 765-588-3341, cladam@prf.org

Source: Abhijit Karve, aakarve@prf.org

Media Contact
Chris Adam
cladam@prf.org

Tags: Technology TransferTechnology/Engineering/Computer Science
Share13Tweet8Share2ShareShareShare2

Related Posts

7T MRI Feasibility Study Maps Diffuse Lipid Alterations in Multiple Sclerosis

7T MRI Feasibility Study Maps Diffuse Lipid Alterations in Multiple Sclerosis

November 17, 2026
Negative Pressure Therapy Linked to Shorter Healing After Endoscopic Pilonidal Sinus Treatment

Negative Pressure Therapy Linked to Shorter Healing After Endoscopic Pilonidal Sinus Treatment

November 17, 2026

Combining Remimazolam with Propofol Lowers Dose Requirements but Alters Recovery Dynamics

November 17, 2026

China’s Fair Competition Review System Curbs Inefficient Investment Across Listed Firms

November 17, 2026
Please login to join discussion

POPULAR NEWS

  • Structured IDEA Expert Elicitation Framework Enhances Design of Rare Disease Trials

    Structured IDEA Expert Elicitation Framework Enhances Design of Rare Disease Trials

    29 shares
    Share 12 Tweet 7
  • Syndesmotic Fixation Speeds Early Ankle Recovery but Matches Non-Fixation at Two Years

    29 shares
    Share 12 Tweet 7
  • German Nationwide Survey Identifies Workplace Bullying Patterns Across Industries and Age Groups

    29 shares
    Share 12 Tweet 7
  • TCAD Simulations Identify Efficiency Gains for Sustainable CZTS Solar Cells

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

7T MRI Feasibility Study Maps Diffuse Lipid Alterations in Multiple Sclerosis

Negative Pressure Therapy Linked to Shorter Healing After Endoscopic Pilonidal Sinus Treatment

Combining Remimazolam with Propofol Lowers Dose Requirements but Alters Recovery Dynamics

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.